Home
    Disclaimer
    ← Back to 3-Cl-PCP
    3-Cl-PCP molecular structure

    3-Cl-PCP Stats & Data

    Dissociative Research-chemical
    3-chloro-pcp
    PubChem
    MW277.8
    FormulaC17H24ClN
    LogP4.3
    IUPAC1-[1-(3-chlorophenyl)cyclohexyl]piperidine
    InChIKeyHUHBTESMMFLCAN-UHFFFAOYSA-N
    Psychoactive Class Dissociative

    Receptor Profile

    Receptor Actions

    Antagonists
    NMDA receptor antagonist (noncompetitive)
    Inhibitors
    Dopamine reuptake inhibitor

    Receptor Binding

    NMDA antagonist

    History & Culture

    3-Cl-PCP is a novel dissociative from the arylcyclohexylamine class that emerged as part of a wave of designer drugs in the early 2020s. It was first identified in Slovenia in December 2020, marking its initial appearance on the recreational drug market. The substance belongs to a group of novel dissociatives that were developed and marketed around the same time, reportedly designed to produce effects similar to those of MXE (methoxetamine). This cohort of related compounds includes 3-F-PCP, 3-Me-PCP, DMXE, MXPr, MXiPr, and HXE, all of which appeared on the research chemical market during this period.

    Toxicity

    PsychonautWiki

    The toxicity and long-term health effects of recreational 3-Cl-PCP use have not been studied in any scientific context and the exact toxic dosage is unknown. This is because 3-Cl-PCP has an extremely brief history of human usage.

    Effect Profile

    Curated + 1 Reports
    Dissociative 6.6

    Strong dissociative depth, motor impairment, and mania with moderate insight

    Dissociative Depth×3
    10
    Mania / Compulsion×1
    8
    Insight / Novel Thought×2
    7
    Motor / Sensory Impairment×1
    10
    Based on reports from:
    Erowid Experience Reports PsychonautWiki 3-Cl-PCP

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Oral
    15 minutes - 1.0 hours
    30 minutes - 1.5 hours
    1-3 hours
    2-4 hours
    6-24 hours
    Insufflated
    4-19 minutes
    15-30 minutes
    1-3 hours
    2-4 hours
    6-24 hours
    Intramuscular
    1-4 minutes
    4-15 minutes
    1-3 hours
    2-4 hours
    6-24 hours
    Smoked
    1-4 minutes
    4-15 minutes
    1-3 hours
    2-4 hours
    6-24 hours

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1d Half tolerance 21d Baseline ~28d

    Experience Report Analysis

    Erowid
    1 Reports
    2020–2020 Date Range
    1 With Age Data

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Read full reports on Erowid →

    Legal Status

    Country Status Notes
    Germany Controlled (NpSG) Controlled substance under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act), which prohibits the production, distribution, and import of new psychoactive substances.
    Hungary Illegal Became a controlled substance in April 2021. Production, distribution, and possession are prohibited under national drug legislation.
    Switzerland Uncontrolled Not listed as a controlled substance as of 2021. However, legal status may have changed since this assessment.
    United Kingdom Illegal Prohibited under the Psychoactive Substances Act 2016. It is illegal to possess, produce, supply, or import this substance.

    References

    Data Sources

    Cited References

    ← Back to 3-Cl-PCP